Clinical Genetics · Philadelphia, PA
NPI
1336650456
Since 2017
Specialty
Clinical Genetics
Code 207SG0201X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
3401 Civic Center Blvd
Philadelphia, PA, 19104
Phone (267) 426-7868
Groups this clinician bills Medicare through
Medicare paid, 2024
$2,296
18 services
Medicare patients, 2024
14
Average age 40
Drug cost, 2024
$2.8M
115 prescriptions
Company payments, 2025
$0
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kim Choong Wen Ng was code 99215 (office e&m - established), 15 times for 11 patients. In total Kim Choong Wen Ng billed 18 services in 2 codes, and Medicare paid $2,296.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-07-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 15 | 11 | $131.42 | $1,971 |
By year: 2023 $2,527 for 22 services; 2024 $2,296 for 18 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kim Choong Wen Ng prescribed most often to Medicare patients was Ravicti (Glycerol Phenylbutyrate), with 40 prescriptions and refills. In total Kim Choong Wen Ng wrote 115 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ravicti Glycerol Phenylbutyrate | 40 | 40 | Under 11 | $2.8M |
| Levocarnitine Generic | 28 | 32 | Under 11 | $1,635 |
| Cystadane Betaine | 24 | 24 | Under 11 | $35K |
| Leucovorin Calcium Generic | 13 | 13 | Under 11 | $2,394 |
Brand drugs: 65 claims; generic drugs: 50 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kim Choong Wen Ng $0 (- in general payments such as food, travel and fees) from 1 company.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.